Table of Contents
ISRN Pharmacology
Volume 2014 (2014), Article ID 602436, 6 pages
http://dx.doi.org/10.1155/2014/602436
Research Article

Antifungal, Antileishmanial, and Cytotoxicity Activities of Various Extracts of Berberis vulgaris (Berberidaceae) and Its Active Principle Berberine

1Leishmaniasis Research Center, Kerman University of Medical Sciences, Kerman 76169-14119, Iran
2Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad 68138-33946, Iran
3Department of Medical Parasitology and Mycology, Kerman University of Medical Sciences, Kerman 76169-14114, Iran
4Department of Medical Parasitology and Mycology, Lorestan University of Medical Sciences, Khorramabad 68138-33946, Iran
5Department of Pharmacognosy, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman 76169-14111, Iran
6Department of Entomology, Islamic Azad University, Science and Research Branch, Tehran 14778-93855, Iran

Received 6 January 2014; Accepted 18 February 2014; Published 10 March 2014

Academic Editors: M. Brunner, K. Cimanga, and G. Edwards

Copyright © 2014 Hossein Mahmoudvand et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. Weitzman and R. C. Summerbell, “The dermatophytes,” Clinical Microbiology Reviews, vol. 8, no. 2, pp. 240–259, 1995. View at Google Scholar · View at Scopus
  2. B. E. de Pauw, “Is there a need for new antifungal agents,” Clinical Microbiology and Infection, vol. 6, no. 2, pp. 23–28, 2000. View at Google Scholar · View at Scopus
  3. P. Adimi, S. J. Hashemi, M. Mahmoudi et al., “In-vitro activity of 10 antifungal agents against 320 dermatophyte strains using microdilution method in Tehran,” Iranian Journal of Pharmaceutical Research, vol. 12, no. 3, pp. 537–545, 2013. View at Google Scholar
  4. World Health Organization, “Control of the Leishmaniasis,” Technical Report Series 949, WHO, Geneva, Switzerland, 2010. View at Google Scholar
  5. P. Desjeux, “Leishmaniasis: current situation and new perspectives,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 27, no. 5, pp. 305–318, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Sharifi, I. Sharifi, M. Zarean et al., “Spatial distribution and molecular identification of leishmania species from endemic foci of South-Eastern Iran,” Iranian Journal of Parasitology, vol. 7, no. 1, pp. 45–52, 2012. View at Google Scholar · View at Scopus
  7. R. Hadighi, M. Mohebali, P. Boucher, H. Hajjaran, A. Khamesipour, and M. Ouellette, “Unresponsiveness to glucantime treatment in Iranian cutaneous Leishmaniasis due to drug-resistant Leishmania tropica parasites,” PLoS Medicine, vol. 3, no. 5, pp. 659–667, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. D. O. Santos, C. E. R. Coutinho, M. F. Madeira et al., “Leishmaniasis treatment—a challenge that remains: a review,” Parasitology Research, vol. 103, no. 1, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Sazgarnia, N. Zabolinejad, P. Layegh et al., “Antileishmanial activity of liposomal clarithromycin against Leishmania major promastigotes,” Iranian Journal of Basic Medical Sciences, vol. 15, no. 5, pp. 1210–1214, 2012. View at Google Scholar
  10. L. G. Rocha, J. R. G. S. Almeida, R. O. Macêdo, and J. M. Barbosa-Filho, “A review of natural products with antileishmanial activity,” Phytomedicine, vol. 12, no. 6-7, pp. 514–535, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Imanshahidi and H. Hosseinzadeh, “Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine,” Phytotherapy Research, vol. 22, no. 8, pp. 999–1012, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Ivanovska and S. Philipov, “Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids,” International Journal of Immunopharmacology, vol. 18, no. 10, pp. 553–561, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Küpeli, M. Kosar, E. Yesilada, K. Hüsnü, and C. Baser, “A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species,” Life Sciences, vol. 72, no. 6, pp. 645–657, 2002. View at Publisher · View at Google Scholar
  14. M. L. Freile, F. Giannini, G. Pucci et al., “Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla,” Fitoterapia, vol. 74, no. 7-8, pp. 702–705, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Fata, H. Rakhshandeh, F. Berenji, and A. Jalalifard, “treatment of cutaneous leishmaniasis in murine model by alcoholic extract of Berberis vulgaris,” Iranian Journal of Parasitology, vol. 1, no. 1, pp. 39–42, 2006. View at Google Scholar
  16. Y. Kaneda, M. Torii, T. Tanaka, and M. Aikawa, “In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis,” Annals of Tropical Medicine and Parasitology, vol. 85, no. 4, pp. 417–425, 1991. View at Google Scholar · View at Scopus
  17. J. L. Vennerstrom, J. K. Lovelace, V. B. Waits, W. L. Hanson, and D. L. Klayman, “Berberine derivatives as anti-leishmanial drugs,” Antimicrobial Agents and Chemotherapy, vol. 34, no. 5, pp. 918–921, 1990. View at Google Scholar · View at Scopus
  18. R. Ghaderi and P. Maleki Nejad, “Evaluation of anti-candidal effects of Berberis vulgaris root extracts (methanolic and aqueous) and comparing their effects with those clotrimazole,” Journal of Birjand University of Medical Sciences, vol. 13, no. 2, pp. 42–48, 2006. View at Google Scholar
  19. K. Nakamoto, S. Sadamori, and T. Hamada, “Effects of crude drugs and berberine hydrochloride on the activities of fungi,” The Journal of Prosthetic Dentistry, vol. 64, no. 6, pp. 691–694, 1990. View at Google Scholar · View at Scopus
  20. Clinical and Laboratory Standards Institute (CLSI), “Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi,” Approved Standard M38-A, Wayne, 2008. View at Google Scholar
  21. A. Shokri, I. Sharifi, A. Khamesipour et al., “The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate,” Parasitology Research, vol. 110, no. 3, pp. 1113–1117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Garcia, L. Monzote, R. Scull, and P. Herrera, “Activity of cuban plants extracts against Leishmania amazonensis,” ISRN Pharmacology, vol. 2012, Article ID 104540, 7 pages, 2012. View at Publisher · View at Google Scholar
  23. B. Weniger, S. Robledo, G. J. Arango et al., “Antiprotozoal activities of Colombian plants,” Journal of Ethnopharmacology, vol. 78, no. 2-3, pp. 193–200, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. F. A. Jones, “Herbs—useful plants. Their role in history and today,” European Journal of Gastroenterology and Hepatology, vol. 8, no. 12, pp. 1227–1231, 1996. View at Google Scholar · View at Scopus
  25. M. M. Cowan, “Plant products as antimicrobial agents,” Clinical Microbiology Reviews, vol. 12, no. 4, pp. 564–582, 1999. View at Google Scholar · View at Scopus
  26. A. R. McCutcheon, S. M. Ellis, R. E. W. Hancock, and G. H. N. Towers, “Antibiotic screening of medicinal plants of the British Columbian native peoples,” Journal of Ethnopharmacology, vol. 37, no. 3, pp. 213–223, 1992. View at Publisher · View at Google Scholar · View at Scopus
  27. K. S. Park, K. C. Kang, J. H. Kim, D. J. Adams, T. N. Johng, and Y. K. Paik, “Differential inhibitory effects of protoberberines on sterol and chitin biosyntheses in Candida albicans,” Journal of Antimicrobial Chemotherapy, vol. 43, no. 5, pp. 667–674, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Han and J. H. Lee, “Berberine synergy with amphotericin B against disseminated candidiasis in mice,” Biological and Pharmaceutical Bulletin, vol. 28, no. 3, pp. 541–544, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. W. D. Sheng, M. S. Jiddawi, X. Q. Hong, and S. M. Abdulla, “Treatment of chloroquine—resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole,” East African Medical Journal, vol. 74, no. 5, pp. 283–284, 1997. View at Google Scholar · View at Scopus
  30. S. Rouhani, N. Salehi, M. Kamalinejad, and F. Zayeri, “Efficacy of Berberis vulgaris aqueous extract on viability of Echinococcus granulosus protoscolices,” Journal of Investigative Surgery, vol. 26, no. 6, pp. 347–351, 2013. View at Publisher · View at Google Scholar
  31. L. Peychev, “Pharmacological investigation on the cardiovascular effects of Berberis vulgaris on tested animals,” Pharmacia, vol. 52, no. 1-2, pp. 118–121, 2005. View at Google Scholar · View at Scopus
  32. C. C. Lin, L. T. Ng, F. F. Hsu, D. E. Shieh, and L. C. Chiang, “Cytotoxic effects of Coptis chinensis and Epimedium sagittatum extracts and their major constituents (berberine, coptisine and icariin) on hepatoma and leukaemia cell growth,” Clinical and Experimental Pharmacology and Physiology, vol. 31, no. 1-2, pp. 65–69, 2004. View at Publisher · View at Google Scholar · View at Scopus